United States Antidiabetic Biguanides Market Report 2017

January 2017 | 112 pages | ID: UB4A3C991E4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antidiabetic Biguanides

Revenue, means the sales value of Antidiabetic Biguanides

This report studies sales (consumption) of Antidiabetic Biguanides in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Anderson Hay & Grain Inc.
• Border Valley
• Sanofi
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk
• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Boehringer Ingelheim

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Metformin IR
• Metformin SR

Split by applications, this report focuses on sales, market share and growth rate of Antidiabetic Biguanides in each application, can be divided into

• Hospital
• Clinic

Contents

United States Antidiabetic Biguanides Market Report 2017

1 ANTIDIABETIC BIGUANIDES OVERVIEW

1.1 Product Overview and Scope of Antidiabetic Biguanides
1.2 Classification of Antidiabetic Biguanides
  1.2.1 Metformin IR
  1.2.2 Metformin SR
1.3 Application of Antidiabetic Biguanides
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antidiabetic Biguanides (2011-2021)
  1.4.1 United States Antidiabetic Biguanides Sales and Growth Rate (2011-2021)
  1.4.2 United States Antidiabetic Biguanides Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTIDIABETIC BIGUANIDES COMPETITION BY MANUFACTURERS

2.1 United States Antidiabetic Biguanides Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antidiabetic Biguanides Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antidiabetic Biguanides Average Price by Manufactures (2015 and 2016)
2.4 Antidiabetic Biguanides Market Competitive Situation and Trends
  2.4.1 Antidiabetic Biguanides Market Concentration Rate
  2.4.2 Antidiabetic Biguanides Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTIDIABETIC BIGUANIDES SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Antidiabetic Biguanides Sales and Market Share by States (2011-2016)
3.2 United States Antidiabetic Biguanides Revenue and Market Share by States (2011-2016)
3.3 United States Antidiabetic Biguanides Price by States (2011-2016)

4 UNITED STATES ANTIDIABETIC BIGUANIDES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Antidiabetic Biguanides Sales and Market Share by Type (2011-2016)
4.2 United States Antidiabetic Biguanides Revenue and Market Share by Type (2011-2016)
4.3 United States Antidiabetic Biguanides Price by Type (2011-2016)
4.4 United States Antidiabetic Biguanides Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ANTIDIABETIC BIGUANIDES SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Antidiabetic Biguanides Sales and Market Share by Application (2011-2016)
5.2 United States Antidiabetic Biguanides Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIDIABETIC BIGUANIDES MANUFACTURERS PROFILES/ANALYSIS

6.1 Anderson Hay & Grain Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.1.2.1 Metformin IR
    6.1.2.2 Metformin SR
  6.1.3 Anderson Hay & Grain Inc. Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Border Valley
  6.2.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.2.2.1 Metformin IR
    6.2.2.2 Metformin SR
  6.2.3 Border Valley Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.3.2.1 Metformin IR
    6.3.2.2 Metformin SR
  6.3.3 Sanofi Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Takeda Pharmaceuticals
  6.4.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.4.2.1 Metformin IR
    6.4.2.2 Metformin SR
  6.4.3 Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly
  6.5.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.5.2.1 Metformin IR
    6.5.2.2 Metformin SR
  6.5.3 Eli Lilly Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Merck & Co.
  6.6.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.6.2.1 Metformin IR
    6.6.2.2 Metformin SR
  6.6.3 Merck & Co. Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
  6.7.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.7.2.1 Metformin IR
    6.7.2.2 Metformin SR
  6.7.3 Novo Nordisk Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb
  6.8.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.8.2.1 Metformin IR
    6.8.2.2 Metformin SR
  6.8.3 Bristol-Myers Squibb Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Pfizer
  6.9.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.9.2.1 Metformin IR
    6.9.2.2 Metformin SR
  6.9.3 Pfizer Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.2 Antidiabetic Biguanides Product Type, Application and Specification
    6.10.2.1 Metformin IR
    6.10.2.2 Metformin SR
  6.10.3 AstraZeneca Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline
6.12 Boehringer Ingelheim

7 ANTIDIABETIC BIGUANIDES MANUFACTURING COST ANALYSIS

7.1 Antidiabetic Biguanides Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidiabetic Biguanides

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antidiabetic Biguanides Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidiabetic Biguanides Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIDIABETIC BIGUANIDES MARKET FORECAST (2016-2021)

11.1 United States Antidiabetic Biguanides Sales, Revenue Forecast (2016-2021)
11.2 United States Antidiabetic Biguanides Sales Forecast by Type (2016-2021)
11.3 United States Antidiabetic Biguanides Sales Forecast by Application (2016-2021)
11.4 Antidiabetic Biguanides Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Biguanides
Table Classification of Antidiabetic Biguanides
Figure United States Sales Market Share of Antidiabetic Biguanides by Type in 2015
Figure Metformin IR Picture
Figure Metformin SR Picture
Table Application of Antidiabetic Biguanides
Figure United States Sales Market Share of Antidiabetic Biguanides by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Antidiabetic Biguanides Sales and Growth Rate (2011-2021)
Figure United States Antidiabetic Biguanides Revenue and Growth Rate (2011-2021)
Table United States Antidiabetic Biguanides Sales of Key Manufacturers (2015 and 2016)
Table United States Antidiabetic Biguanides Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic Biguanides Sales Share by Manufacturers
Figure 2016 Antidiabetic Biguanides Sales Share by Manufacturers
Table United States Antidiabetic Biguanides Revenue by Manufacturers (2015 and 2016)
Table United States Antidiabetic Biguanides Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antidiabetic Biguanides Revenue Share by Manufacturers
Table 2016 United States Antidiabetic Biguanides Revenue Share by Manufacturers
Table United States Market Antidiabetic Biguanides Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antidiabetic Biguanides Average Price of Key Manufacturers in 2015
Figure Antidiabetic Biguanides Market Share of Top 3 Manufacturers
Figure Antidiabetic Biguanides Market Share of Top 5 Manufacturers
Table United States Antidiabetic Biguanides Sales by States (2011-2016)
Table United States Antidiabetic Biguanides Sales Share by States (2011-2016)
Figure United States Antidiabetic Biguanides Sales Market Share by States in 2015
Table United States Antidiabetic Biguanides Revenue and Market Share by States (2011-2016)
Table United States Antidiabetic Biguanides Revenue Share by States (2011-2016)
Figure Revenue Market Share of Antidiabetic Biguanides by States (2011-2016)
Table United States Antidiabetic Biguanides Price by States (2011-2016)
Table United States Antidiabetic Biguanides Sales by Type (2011-2016)
Table United States Antidiabetic Biguanides Sales Share by Type (2011-2016)
Figure United States Antidiabetic Biguanides Sales Market Share by Type in 2015
Table United States Antidiabetic Biguanides Revenue and Market Share by Type (2011-2016)
Table United States Antidiabetic Biguanides Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antidiabetic Biguanides by Type (2011-2016)
Table United States Antidiabetic Biguanides Price by Type (2011-2016)
Figure United States Antidiabetic Biguanides Sales Growth Rate by Type (2011-2016)
Table United States Antidiabetic Biguanides Sales by Application (2011-2016)
Table United States Antidiabetic Biguanides Sales Market Share by Application (2011-2016)
Figure United States Antidiabetic Biguanides Sales Market Share by Application in 2015
Table United States Antidiabetic Biguanides Sales Growth Rate by Application (2011-2016)
Figure United States Antidiabetic Biguanides Sales Growth Rate by Application (2011-2016)
Table Anderson Hay & Grain Inc. Basic Information List
Table Anderson Hay & Grain Inc. Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Anderson Hay & Grain Inc. Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Border Valley Basic Information List
Table Border Valley Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Border Valley Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceuticals Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Antidiabetic Biguanides Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Antidiabetic Biguanides Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Antidiabetic Biguanides Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Biguanides
Figure Manufacturing Process Analysis of Antidiabetic Biguanides
Figure Antidiabetic Biguanides Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Biguanides Major Manufacturers in 2015
Table Major Buyers of Antidiabetic Biguanides
Table Distributors/Traders List
Figure United States Antidiabetic Biguanides Production and Growth Rate Forecast (2016-2021)
Figure United States Antidiabetic Biguanides Revenue and Growth Rate Forecast (2016-2021)
Table United States Antidiabetic Biguanides Production Forecast by Type (2016-2021)
Table United States Antidiabetic Biguanides Consumption Forecast by Application (2016-2021)
Table United States Antidiabetic Biguanides Sales Forecast by States (2016-2021)
Table United States Antidiabetic Biguanides Sales Share Forecast by States (2016-2021)